ACTG
Acacia Research Corporation NASDAQ$5.16
Mkt Cap $497.8M
52w Low $2.99
95.2% of range
52w High $5.27
50d MA $4.74
200d MA $3.88
P/E (TTM)
22.3x
EV/EBITDA
3.1x
P/B
0.8x
Debt/Equity
0.2x
ROE
4.0%
P/FCF
6.2x
RSI (14)
—
ATR (14)
—
Beta
0.45
50d MA
$4.74
200d MA
$3.88
Avg Volume
325.2K
About
Acacia Research Corporation, together with its subsidiaries, invests in intellectual property and related absolute return assets; and engages in the licensing and enforcement of patented technologies. The company operates through two segments, Intellectual Property Operations and Industrial Operations. The company owns or controls the rights to various patent portfolios, which include U.S. patents…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AMC | -0.14 | 0.03 | +121.4% | 5.00 | +1.0% | -2.6% | -2.4% | -1.4% | +0.8% | +0.8% | — |
| Nov 5, 2025 | AMC | -0.14 | -0.01 | +92.9% | 3.62 | +0.0% | -1.1% | -1.7% | +0.8% | +2.5% | +0.3% | — |
| Aug 6, 2025 | AMC | -0.14 | -0.06 | +57.1% | 3.26 | +0.6% | +2.1% | -0.3% | +0.9% | +2.5% | +5.5% | — |
| May 8, 2025 | AMC | -0.06 | 0.34 | +666.7% | 3.54 | -0.3% | +6.5% | +9.9% | +9.6% | +5.4% | +4.8% | — |
| Mar 13, 2025 | AMC | -0.08 | -0.07 | +12.5% | 3.61 | +0.8% | -0.8% | -2.8% | -4.7% | -3.6% | -4.4% | — |
| Nov 12, 2024 | AMC | -0.01 | -0.09 | -1501.8% | 4.31 | +0.7% | +0.0% | +1.4% | +2.8% | +4.6% | +2.6% | — |
| Aug 8, 2024 | AMC | 0.08 | -0.02 | -125.0% | 4.92 | -2.4% | -6.9% | -8.7% | -8.9% | -6.9% | -5.1% | — |
| May 9, 2024 | AMC | — | 0.06 | — | 5.18 | -2.3% | -1.9% | -0.4% | +2.1% | +2.3% | +3.9% | — |
| Mar 14, 2024 | AMC | 0.07 | 0.62 | +785.7% | 3.98 | +8.0% | +16.8% | +23.4% | +26.9% | +29.9% | +30.2% | — |
| Nov 13, 2023 | AMC | 0.12 | -0.06 | -150.0% | 3.63 | +2.8% | +1.7% | +2.2% | +2.2% | +3.0% | +3.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 | Craig-Hallum | Maintains | Buy → Buy | — | $5.00 | $5.05 | +1.0% | -2.6% | -2.4% | -1.4% | +0.8% | +0.8% |
| Mar 15 | Craig-Hallum | Maintains | Buy → Buy | — | $3.98 | $4.30 | +8.0% | +16.8% | +23.4% | +26.9% | +29.9% | +30.2% |
| May 22 | Craig-Hallum | Maintains | Buy → Buy | — | $2.32 | $2.59 | +11.6% | +12.1% | +11.9% | +10.8% | +10.8% | +11.6% |
| Jul 29 | Barclays | Maintains | Underweight → Underweight | — | $5.09 | $5.25 | +3.1% | +6.3% | +13.0% | +16.1% | +15.9% | +11.0% |
| Jan 5 | Barclays | Downgrade | Equal Weight → Underweight | — | $4.18 | $3.96 | -5.3% | -6.0% | +0.0% | -9.8% | -9.2% | -13.9% |
| Feb 20 | JP Morgan | Maintains | Overweight → Overweight | — | $13.28 | $12.17 | -8.4% | -3.4% | -4.9% | -2.5% | -2.1% | -5.3% |
| Feb 19 | Barclays | Maintains | Equal Weight → Equal Weight | — | $13.31 | $13.32 | +0.1% | -0.2% | -3.6% | -5.1% | -2.7% | -2.3% |
| Oct 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $15.23 | $15.75 | +3.4% | +1.3% | +11.0% | +11.7% | +14.9% | +10.5% |
| Jul 29 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.24 | $18.37 | +0.7% | -3.8% | -4.4% | -6.5% | -8.7% | -8.1% |
| Apr 22 | JP Morgan | Maintains | Overweight → Overweight | — | $15.86 | $15.85 | -0.1% | +8.0% | +6.7% | +6.7% | +3.7% | +0.6% |
Recent Filings
8-K
Unknown — 8-K Filing
Acacia Research's strong Q4 2025 revenue growth and 34.7% Adjusted EBITDA margin demonstrate operational efficiency and profitability improvements, supporting the stock's potential for continued appreciation and dividend sustainability.
Mar 11
8-K · 5.02
!!! Very High
Acacia Research Corporation -- 8-K 5.02: Executive Change
Executive leadership change at Acacia Research could signal strategic repositioning or operational challenges, affecting investor confidence and the company's ability to execute its intellectual property licensing strategy.
Feb 6
Data updated apr 24, 2026 10:44am
· Source: massive.com